The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to-consumer offering.

Aflac on Friday disclosed a cybersecurity incident in which personal information of its customers may have been compromised, ...

From UNC Health suing Aetna and Humana to Purdue Pharma reaching a settlement over its role in the opioid epidemic, here are 10 healthcare industry lawsuits, settlements and legal developments that ...

Oregon health officials found that the rising prices — not increased use of services — is what’s fueling the state’s health ...

Opinion: Companies should be mindful of state attorneys general expanding their role as aggressive regulators in the consumer ...

JPMorgan just nudged UnitedHealth’s price target from $405 to $418, still cheering it on with an “Overweight” rating. They ...

JPMorgan analyst Lisa Gill upgraded UnitedHealth Group's target price to $418 from $405 and maintained an Overweight rating ...

UnitedHealth's diversified model, robust financials, and undervaluation signal a 24% upside. Click to read more on why I ...

If you're seeking dividend income, bravo -- because dividends are hard to beat. One dividend payer to consider is ...

A fight over the power of outside funders to influence lawsuits is unfolding in Chicago federal court, where leading ...

UnitedHealth's selloff is partly a market overreaction to temporary Medicare Advantage headwinds. Read why investors should ...